2 assets in Gastrin-Producing Neuroendocrine Tumor

Therapeutic assets addressing Gastrin-Producing Neuroendocrine Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Capecitabine Gastrin-Producing Neuroendocrine Tumor	ECOG-ACRIN Cancer Research Group	P2	B (57)
Edotreotide Gastrin-Producing Neuroendocrine Tumor	British Columbia Cancer Agency	P2	CCC (52)